A000314

Organization name

WH Pharmawerk Weinböhla GmbH

SRN

DE-MF-000006741

Manufacturer status

Active

5 warnings recorded — scroll inside the panel to see all entries.

• CW999

  Potential interaction with other products (e.g. medicines, food): Activomin® should not be taken within a period of 2 hours of other medication having been taken (especially such with a low therapeutic effect, e.g. hormones, chemotherapeutic substances) and food supplements (vitamins, minerals), as their effects are impaired by the binding characteristic of the humin acids, thereby resulting in interactions occurring. Activomin® should only be taking after consulting the treating physician when taking retard preparations.
• CW999

  Activomin® is not suitable for the treatment of constipation.
• CW999

  Keep Activomin® out of the reach of children!
• CW999

  Contraindication: Hypersensitivity toward humin acids or the capsule material.
• CW999

  The content of the capsules has a strong colouring effect.

Primary placement in Germany; available across 2 countries total.

Trade name

not provided

UDI-DI code

04260631560229

Basic UDI-DI

B-04260631560229

Reference / catalog number

A000314

Issuing entity

GS1

Risk category

Class IIa

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

Activomin® is a medical product in capsule form for oral use: • with unspecific diarrhoea, • with gastrointestinal symptoms, • for the binding of harmful substances and toxins.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

• 60 MU999

• G0499ORALLY ADMINISTERED GASTROINTESTINAL DEVICES - OTHER

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification